The American Heart Association is concerned about the risk of cardiac problems in child patients using drugs for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The concerns are centered on the fact that underlying cardiac problems may worsen with the use of these drugs. The American Heart Association offered a recommendation that all children be screened for undiagnosed cardiac problems before taking drugs for their ADHD.
While not every child patient will need the cardiac screening, the American Heart Association believes the health of children taking ADHD drugs could be improved by the diagnosis of possible heart problems prior to taking drugs for their ADHD.
The recommendations made by the American Heart Association include:
- Taking a detailed patient history, including family history of heart problems and heart disease.
- A complete physical examination of the patient before prescription ADHD drugs are given.
- Blood pressure and heart rate monitoring.
- ECG (Electrocardiogram) test.
- Consultations with a Pediatric cardiologist as needed.
If the patients are cleared of any heart related problems, the American Heart Association recommends continuing blood pressure screening every month to every three months along with full checkups every three to six months.
With more than 2 million children currently taking ADHD drugs and an estimate of up to 12 % of the child population suffering from ADHD, the American Heart Association hopes these guidelines will improve the care given to children suffering with this neurobehavioral disorder.
At the heart of the concern is the “stimulant” nature of the drugs prescribed for ADHD. Belonging to the class of drugs along with such Stimulants as amphetamines, the effects on the heart are a common concern. This class of drugs has been noted as increasing the heart rates and blood pressure levels of those taking the drugs.
The most common ADHD drugs are Adderall, Concerta, Dexedrine, Focalin, Ritalin, Ritalin SR, Ritalin SA, Metadate ER and Metadate CD. Strattera, a newer drug, does not fall into the “stimulant” class of drugs and thus is being recommended as a healthier alternative for both children and adults who suffer from ADHD.
It is noted that serious cardiac side effects and deaths associated with ADHD drugs and “stimulant” medications, in general, is very low. With the use of preventative and diagnostic testing, the chance of these side effects can be lessened to an even greater degree.
